Latest Michael J. Fox Foundation for Parkinson Stories
PPMI now recruiting individuals with genetic mutation linked to Gaucher disease NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI),
Baseline paper highlights findings from Fox Trial Finder, first smart-matching clinical research recruitment tool for Parkinson's disease NEW YORK, Feb.
Fellowship Program Building a Workforce of Parkinson's Disease Care and Research Specialists NEW YORK, Dec. 2, 2014 /PRNewswire-USNewswire/ -- The Michael J.
NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J.
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
Paper Addresses Challenges and Explores Opportunities to Stimulate Repurposing of FDA-Approved Drugs for Alzheimer's, Parkinson's and Related Diseases NEW YORK, June 26, 2014 /PRNewswire-USNewswire/
NEW YORK, April 23, 2014 /PRNewswire-USNewswire/ -- The Michael J.
NEW YORK, March 31, 2014 /PRNewswire-USNewswire/ -- Results out of a study funded by The Michael J.
NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J.
NEW YORK, Feb. 20, 2014 /PRNewswire-USNewswire/ -- As medical researchers across disease states pursue better treatments, they all share one limiting factor.
- The governor of a province or people.